HIGHLIGHTS
- who: Anne-Rose W. Schut from the Department of Medical Oncology, Erasmus MC Institute, University Medical Center Rotterdam, the Netherlands have published the paper: In desmoid-type fibromatosis cells sorafenib induces ferroptosis and apoptosis, which are enhanced by autophagy inhibition, in the Journal: (JOURNAL) of 23/Nov/2021
- what: The aim of this study is to investigate the antitumour effects of sorafenib in DTF Induction of cell death resulting in tumour stabilization or regression is one of the main goals of DTF systemic treatments. The results of this study show that sorafenib is capable of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.